Concise guidance: diagnosis and management of polymyalgia rheumatica
- PMID: 20726461
- PMCID: PMC5873556
- DOI: 10.7861/clinmedicine.10-3-270
Concise guidance: diagnosis and management of polymyalgia rheumatica
Abstract
Polymyalgia rheumatica (PMR) is among the most common reasons for long-term steroid prescription with great heterogeneity in presentation, response to steroids and disease course. The British Society for Rheumatology and the British Health Professionals in Rheumatology have recently published guidelines on management of PMR. The purpose of this concise guidance is to draw attention to the full guidelines and provide a safe and specific diagnostic process with advice on management and monitoring--specifically targeted at general practitioners, general physicians and rheumatologists.
Figures
Comment in
-
Polymyalgia rheumatica.Clin Med (Lond). 2010 Dec;10(6):641; author reply 641. doi: 10.7861/clinmedicine.10-6-641. Clin Med (Lond). 2010. PMID: 21413499 Free PMC article. No abstract available.
References
-
- Dasgupta B, Dolan AL, Fernandes L, Panayi G. An initially double-blind controlled 96 week trial of depot methylprednisolone against oral prednisolone in the treatment of polymyalgia rheumatica. Brit J Rheumatol. 1998;37:189–95. doi: 10.1093/rheumatology/37.2.189. doi: 10.1093/rheumatology/37.2.189. - DOI - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
